Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI (OPTIMUM)

Contact information

icon Laurence Klotz, Dr

icon University of Alberta

icon Edmonton, Alberta, Canada, T6G1Z1

Basic information

icon N/A

icon N/A Age

icon 1200 Enrollment

icon
Cancer Prostate Cancer

Trial Details

Brief Summary

OPTIMUM is a study designed to compare the ability of ultra-high resolution transrectal micro-ultrasound (microUS) and multiparametric MRI (mpMRI)/US fusion to guide prostate biopsy.

Official Title

Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI: A 3-arm Randomized Controlled Trial Evaluating the Role of 29MHz Micro-ultrasound in Guiding Prostate Biopsy in Men With Clinical Suspicion of Prostate Cancer.

Selection Criteria

Eligibility Inclusion Criteria
    - Men indicated for prostate biopsy due to elevated PSA and/or abnormal DRE
    - No history of prior prostate biopsy
    - No history of genitourinary cancer, including prostate cancer
    - 18 years or older
    - No contraindications to biopsy
    - No contraindications to mpMRI
    - No history of mpMRI for clinical investigation of prostate cancer within 12 months prior to screening and enrollment in the study
Eligibility Exclusion Criteria
    - History of prior prostate biopsy
    - History of genitourinary cancer, including prostate cancer
    - Contraindications to biopsy
    - Contraindications to mpMRI